Pfizer chasing AstraZeneca in potential $100 billion deal

LONDON (Reuters) – U.S. drugmaker Pfizer Inc is working on its next move in a potential $100 billion bid battle for Britain’s AstraZeneca Plc after having two bids rejected, as deal-making grips the healthcare industry.



Link to article: feeds.reuters.com/~r/reuters/businessNews/~3/W7UP5YLQhI0/story01.htm

Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *